sodium ascorbate solution 112.49mg/ml
orthomolecular medisearch laboratories pty ltd trading as biological therapies - sodium ascorbate, quantity: 112.49 mg/ml (equivalent: ascorbic acid, qty 100 mg/ml) - injection - excipient ingredients: water for injections - for the treatment of vitamin c deficiency when oral administration is not feasible.
troy invigorate as injection
troy laboratories pty ltd - sodium arsanilate - parenteral liquid/solution/suspension - sodium arsanilate mineral-arsenic active 50.0 mg/ml - nutrition & metabolism - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - arsenic injection
nv jurocyl injection
ceva animal health pty ltd - sodium arsanilate - parenteral liquid/solution/suspension - sodium arsanilate mineral-arsenic active 50.0 mg/ml - nutrition & metabolism - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - arsenic injection
sodium chloride 0.45 % injection
neopharm (israel) 1996 ltd - sodium chloride - solution for injection - sodium chloride 0.45 g / 100 ml - sodium chloride - sodium chloride - supply of water for administration of electrolytes. vehicle for therapeutic regimen.
sodium chloride 0.9%
demo s.a. pharmaceutical industry 21st km national road athens - lamia 14568 krioneri, greece - sodium chloride - solution for injection - sodium chloride 9 mg/ml - blood substitutes and perfusion solutions
sodium valproate 400mg powder and solvent for solution for injection/infusion
noridem enterprises ltd - sodium valproate - powder and solvent for solution for injection/infusion - 400mg - anti-epileptics; fatty acid derivatives - the treatment of epileptic patients who would normally be maintained on oral sodium valproate and for whom oral therapy is temporarily not possible.
ephedrine hydrochloride sxp ephedrine hydrochloride 30mg / ml solution for injection ampoule
southern cross pharma pty ltd - ephedrine hydrochloride, quantity: 30 mg - injection, solution - excipient ingredients: water for injections - ephedrine hydrochloride injection is indicated in the treatment of hypotension secondary to spinal anaesthesia.
palonosetron dr reddy's palonosetron (as hydrochloride) 250 microgram/5 ml solution for injection vial
dr reddys laboratories australia pty ltd - palonosetron hydrochloride, quantity: 280 microgram (equivalent: palonosetron, qty 250 microgram) - injection, solution - excipient ingredients: mannitol; sodium acetate trihydrate; water for injections; hydrochloric acid; sodium hydroxide - palonosetron injection is indicated for prevention of nausea and vomiting induced by cytotoxic chemotherapy.
precedex ready to use dexmedetomidine hydrochloride 400 micrograms/100 ml injection for intravenous infusion bottle
pfizer australia pty ltd - dexmedetomidine hydrochloride, quantity: 4.72 microgram/ml (equivalent: dexmedetomidine, qty 4 microgram/ml) - injection, intravenous infusion - excipient ingredients: sodium chloride; water for injections - intensive care unit (icu) sedation: for sedation of initially intubated adult patients during treatment in an intensive care setting. the use of precedex ready to use by continuous infusion in these patients should not exceed 24 hours.,procedural sedation: for sedation of non-intubated adult patients prior to and/or during surgical and other procedures.
precedex ready to use dexmedetomidine hydrochloride 200 micrograms/50 ml injection for intravenous infusion bottle
pfizer australia pty ltd - dexmedetomidine hydrochloride, quantity: 4.72 microgram/ml (equivalent: dexmedetomidine, qty 4 microgram/ml) - injection, intravenous infusion - excipient ingredients: sodium chloride; water for injections - intensive care unit (icu) sedation: for sedation of initially intubated adult patients during treatment in an intensive care setting. the use of precedex ready to use by continuous infusion in these patients should not exceed 24 hours.,procedural sedation: for sedation of non-intubated adult patients prior to and/or during surgical and other procedures.